Navigation Links
Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
Date:5/12/2009

- Presentation to Include Partnering Strategy and Process for Picoplatin -

SOUTH SAN FRANCISCO, Calif., May 12 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that Ronald Martell, president and chief operating officer, will present at the BIO International Convention on Tuesday, May 19, at 3:20 p.m. Eastern Time in Atlanta. Mr. Martell will provide an overview of the Company's lead product candidate, picoplatin, and outline the Company's partnering strategy and process for picoplatin.

"We believe that picoplatin's potential for technical, clinical and regulatory success in small cell lung cancer and the upcoming proof-of-concept data in the colorectal and prostate cancers programs make the compound an attractive partnering asset to pharmaceutical and biotech companies," said Mr. Martell. "We are seeking a global development and commercialization partnership for picoplatin with co-development and U.S. co-promotion rights. This global partner would share our vision that picoplatin represents a pipeline in a product and enable us to maximize the value of picoplatin worldwide."

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum chemotherapy. To date, clinical studies suggest that picoplatin has an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinatio
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
2. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
5. Poniard Pharmaceuticals Announces Upcoming Conference Participation
6. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
7. Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
8. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
9. Poniard Pharmaceuticals Announces Upcoming Conference Participation
10. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
11. Poniard Pharmaceuticals Announces Upcoming Conference Participation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... ST. LOUIS , June 2, 2015 /PRNewswire/ ... leading Life Science and Technology company, announced today ... XCell Science to launch genetically engineered human ... to advance the research of neurological diseases. These ... portfolio, provide unique and versatile tools for the ...
(Date:6/2/2015)... 02, 2015 Through rare discovery of ... Yancy Corporation is enabling World Scientists to actually ... biological sample, displaying the full nature (position, shape, size, ... , Jeff Porter, Co-Founder of the Yancy Corporation, says, ... – rare. They come once in a lifetime, if ...
(Date:6/1/2015)... YORK , June 1, 2015  Turing ... researcher  Eliseo Oreste Salinas , MD, MSc,  has ... development. Dr. Salinas, who holds a ... pharmacology, brings a record of significant accomplishments in ... psychiatry.  Dr. Salinas has played a ...
(Date:6/1/2015)... YORK , June 1, 2015 ... by the fermentation of sugar or cellulose. Bio-alcohols are ... can be used as a replacement for gasoline in ... grow at a CAGR of 9 percent over the ... The global bio-alcohols market can be segmented into five: ...
Breaking Biology Technology:Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 3Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Global Bio-alcohols Market 2015-2019 2
... structures look like fragments of nanoscopic pearl necklaces. In ... together by means of a special fullerene-binding molecule. Spanish ... the latest issue of the journal Angewandte Chemie. , ... atoms whose linkages resemble the five- and six-sided leather ...
... BERLIN, November 30 Berlin Heart today announced ... for its EXCOR(R),Paediatric VAD, a mechanical cardiac support ... heart failure., The multi-center IDE study is ... the EXCOR(R) Paediatric VAD to support Paediatric,patients. The ...
... ABR-Affinity,BioReagents, a leading global antibody manufacturer, announced today the,company,s ... Annual Meeting in Washington D.C., December 1 - 5, ... most significant of the year in terms,of contact with ... in,this exciting area of research," said Ken Wilczek, President ...
Cached Biology Technology:Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study 2Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study 3ABR-Affinity BioReagents to Exhibit at ASCB in Washington D.C., December 1 - 5, 2007 2
(Date:5/25/2015)... 2015  Australia,s market for wearable technologies is considered ... the advent of several trials and prototypes. The release ... expected to ignite interest in wearables as well as ... . This in turn will spur greater innovation ... partnerships amongst vendors and distributors. Photo ...
(Date:5/22/2015)... According to a new market ... Thermal, Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, ... and Home) - Global Forecast to 2020", published by ... in 2015 to $6.19 Billion by 2020, at a ... data Tables and   43 Figures spread through 140 ...
(Date:5/21/2015)... , May 21, 2015 The ... potential of music for health, today announced a collaborative ... . The partnership will center on collaboration on original ... a first step in the collaboration, The Sync Project ... on "Music as Medicine" in the 2015-2016 academic year.  ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... Jennifer L. Howse, President of the March of Dimes Foundation, ... the nation,s premier advisory group on improving health. ... honor, and it acknowledges the achievements of Dr. Howse,s career, ... Dimes to improving maternal, infant and child health," said Richard ...
... of Missouri indicates that Atlantic Ocean temperatures during the ... by circulation in the deep ocean. These changes in ... understand the consequences of modern increases in greenhouse gases. ... greenhouse climate intervals so that we can understand better ...
... MA (Oct 27, 2011)Researchers have built a map that shows ... with each other . This is the largest and ... how approximately 5000, or one third, of the proteins cooperate ... for decades, trying to unravel the precise connections among the ...
Cached Biology News:Dr. Jennifer L. Howse elected to Institute of Medicine 2Prehistoric greenhouse data from ocean floor could predict earth's future, MU study finds 2Researchers build largest protein interaction map to date 2Researchers build largest protein interaction map to date 3
Request Info...
Request Info...
Request Info...
... Ambion's custom siRNA service provides the ... gene silencing research. Custom siRNAs can be ... 19-21 base target sequence, or by providing ... check out Ambion's Silencer Validated and Silencer ...
Biology Products: